Introduction
Concentric left ventricular hypertrophy (LVH) is a common finding, the majority of which is due to long-term severe hypertension or aortic stenosis. Endomyocardial biopsy (EMB) could help make the diagnosis for unexplained concentric LVH, because for a part of the patients the cause found to be infiltrative cardiomyopathy. However, there are still many unexplained cases of concentric left ventricular hypertrophy for which one make the diagnosis. Previous studies 1 -3 showed that glycogen storage disease, such as Danon disease, could be the cause of hypertrophic cardiomyopathy (HCM). Danon disease is an X-linked dominant lysosomal disease 4 due to a primary deficiency of lysosomeassociated membrane protein 2 (LAMP2). 3 The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in cardiac and skeletal muscle cells. 2, 4 The phenotype typically associated with mutations in the LAMP2 gene is characterized by cardiomyopathy, skeletal myopathy, and mental retardation 2, 3 ; Wolff-Parkinson-White (WPW) syndrome is very common. The phenotypic expression of Danon disease is, however, variable. 2 The objective of the present study was to identify Danon disease from patients with unknown concentric LVH at discharge after EMB. Therefore, we decided systematically to screen the LAMP2 gene in consecutive patients with unexplained concentric LVH after EMB.
Methods

Study population
A total of 50 consecutive patients with concentric LVH [maximum left ventricular wall thickness .13 mm and the ratio between maximum thickness of interventricular septum (IVS) and left ventricular posterior wall (LVPW) , 1.3] , who underwent EMB in Peking Union Medical College Hospital from January 2008 to December 2010, were enrolled. Fourteen patients were diagnosed as cardiac amyloidosis with positive Congo red staining with demonstration of apple-green birefringence under a polarizing microscope. LAMP2 genetic analysis was done for the remaining 36 consecutive unknown patients through EMB after obtaining written informed consent. A total of three patients with positive LAMP2 mutation constituted the study patients (Danon disease group). The remaining 33 patients with unknown concentric LVH constituted the non-Danon disease group (Figure 1) , including diastolic heart failure in 14 patients, arrhythmia referred for catheter ablation or pacemaker implantation in 11 patients (concealed atrioventricular accessory pathways in 3 patients, atrioventricular nodal re-entrant tachycardia in 5 patients, and third degree atrioventricular block in 3 patients), and left bundle branch block in 8 patients.
Data collection
We performed a detailed examination of the medical records of the 36 patients after obtaining the approval from the Institutional Review Board of Peking Union Medical College Hospital. The following information was reviewed and recorded: demographic data including mental retardation, New York Heart Association (NYHA) heart failure class at the time of EMB, ECGs, and ECHOs findings, serum hepatic enzymes [including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH)], creatine kinase (CK), cardiac tropoin I (cTnI), and N-terminal pro-B-type brain natriuretic peptide (NT-proBNP) concentrations as well as isoenzyme electrophoresis of CK. The ECGs were analysed for the following characteristics: rhythm, PR interval, conduction abnormalities (i.e. WPW syndrome), and the voltage of the left ventricle (defined by sum of the voltages of S V1 and R V5/6 ). The ECHOs were analysed for the following characteristics: left atrial (LA) dimension, IVS thickness, LVPW thickness, left ventricular end of diastolic dimension (LVEDD), left ventricular end of systolic dimension (LVESD), left ventricular ejection fraction (LVEF), and E/A ratio. Trans-thoracic ECHO was performed using commercially available GE Vivid 7 Ultrasound machines. Interventricular septal and LVPW thicknesses were measured in standard fashion according to American Society of Echocardiography guidelines. 5 Also, LA dimension and LVEDD as well as LVESD were measured in standard fashion. The left ventricular ejection fraction was assessed using the biplane Simpson's equation from apical twochamber views. Mitral inflow peak velocities of E-and A-waves, were measured in patients in normal sinus rhythm, the E/A-wave ratio was calculated in standard fashion.
Molecular genetics
Genomic DNA was extracted from white blood cells of the 36 patients. We directly sequenced the entire coding regions of the LAMP2 gene, located on Xq24, 6 including the nine exons (1-9a) and intron-exon junctions, with primers previously described. 3 Sequencing reactions were performed with an ABI 3730xl DNA Analyzer (Applied Biosystems, Foster City, CA, USA). Sequence variants were confirmed by re-amplifying and re-sequencing.
Endomyocardial biopsy and electron microscopic examination
Right ventricular biopsy was performed after obtaining the patients' informed consent. Access was by the right internal jugular venous system and fluoroscopic guidance was used to obtain four to six samples of myocardium. Biopsies for the pathological examination were immediately fixed in buffered formaldehyde solution (10%) and embedded in paraffin within 1 day after fixation. These sections were analysed with standard haematoxylin -eosin, Periodic Acid-Schiff (PAS), and Congo red staining in standard fashion. The biopsies were fixed in 2.5% glutaraldehyde and processed for electron microscopic examination. All biopsies were examined by a single, experienced pathologist who was blinded to all other study data.
Follow-up
All the patients were followed up by telephone. The primary outcome was death from any cause. The secondary outcome was cardiovascular hospitalization.
Statistical analysis
Data were reported as mean + standard deviation (SD) for continuous variables or percentage for categorical variables. Differences in baseline characteristics between the two groups were evaluated with the Mann-Whitney U test for all continuous variables, all categorical variables were compared using Fisher's exact test and P-values were not adjusted for the issue of multiple testing. All P-values were twosided and the results were considered statistically significant at the level of P , 0.05. SPSS statistical software of version 13.0 for windows was used for all statistical analyses. 
Results
Clinical features, serum biomarkers, electrocardiographic, and echocardiographic characteristics of the study population
The Danon disease patients were younger than the non-Danon disease patients (15 + 1 vs. 40 + 17 years, P ¼ 0.007). The percentage of age ≤20 years was higher in the Danon disease group than the non-Danon disease group (100 vs. 15%, P ¼ 0.008). The Danon disease group had more NYHA class I at EMB (100 vs. 31%, P ¼ 0.04) and mental retardation (100 vs. 3%, P ¼ 0.001) than the non-Danon disease group. The percentages of ALT more than three times of the upper limit of normal range (ULN, 100 vs. 12%, P ¼ 0.005), AST more than three times of the ULN (100 vs. 3%, P ¼ 0.001), LDH more than three times of ULN (100 vs. 0, P , 0.001), and CK less than three times of the ULN (100 vs. 12%, P ¼ 0. clinical features, serum biomarkers, and electrocardiographic and echocardiographic characteristics of the study population.
Detailed clinical features and serum biomarkers of the three Danon disease patients
All the three patients were male, mean age 15 + 1 years (14-16 years) at diagnosis. The prevalence was 6% (3 of 50) of the total patients with concentric LVH underwent EMB or 8% (3 of 36) of the patients with concentric LVH excluding cardiac amyloidosis. All the three patients had mild mental retardation, mainly involving learning difficulties, and were classified in NYHA functional class I at diagnosis. The presentations of the three patients at diagnosis were variable, from asymptomatic to progressive activity intolerance and syncope. 
Detailed electrocardiographic and echocardiographic characteristics of the three Danon disease patients
All the three patients were in sinus rhythm at diagnosis, two of the three patients with typical WPW syndrome. Patient 3 underwent successful ablation for WPW syndrome. The PR interval was 127 + 64 (80-200) ms. All the three patients' ECGs showed high voltage of the left ventricle; the sums of the voltages of S V1 and R V5/6 were 13.4, 6.5, and 13.2 mV. All the three patients' ECGs showed inverted T-waves. Figure 2 was the ECGs of the three Danon disease patients. There was no left ventricular outflow gradient at rest in the three patients. The maximum LVPW and IVS thickness were 24 + 10 (15-34) mm and 24 + 9 (14 -30) mm, respectively. The LVEF and the LVEDD as well as the LVESD were normal. Patient 3 had enlarged LA dimension and Patient 2 had mild pericardial effusion. Two of the three patients had abnormal left ventricular compliance, one with mildly decreased and another with restrictive left ventricular compliance with the E/A ratio of 2.5. Table 3 summarized the detailed ECG and ECHO characteristics of the three Danon disease patients. Figure 3 was the apical four-chamber views of the three Danon disease patients.
Molecular genetics and cDNA analysis of the three Danon disease patients
Three novel frameshift mutations of LAMP2 gene were identified in the three patients. They were a 1 bp insertion (808_809 insG) in exon 6 (Patient 1), a 4 bp insertion (320_321 insCATC) in exon 3 (Patient 2), and a 2 bp deletion (257_258 delCC) in exon 3, resulting in frameshift mutations and a premature stop codon on cDNA analysis (Figure 4) .
Endomyocardial biopsy and electron microscopic examinations
All the three biopsies were positive PAS and negative Congo red staining. Light microscope examinations revealed the demonstrations of autophagosome-like vesicle. Biopsies from Patients 1 and 3 also had electron microscopic examinations, which revealed some autophagic vacuoles containing glycogen particles ( Figure 5 ).
Discussion
This study is the first attempt to evaluate the prevalence of Danon disease among a large population of patients with concentric LVH who underwent EMB. The prevalence in the total patients with concentric LVH was 6% (3 of 50), or 8% (3 of 36) of the patients excluding cardiac amyloidosis through EMB. The prevalence of 6 -8% in the present study was higher than 1-4% in previous studies 1, 7, 8 probably because of the selection of the study population; previous studies included all HCM patients; however, the present study only included the patients with concentric LVH. The Danon disease patients were younger; significantly elevated serum hepatic enzymes and CK as well as WPW syndrome on ECG were more common than the non-Danon disease patients, and they constituted a very specific entity. All the three Danon disease patients were male teenagers. The mean age was 15 + 1 years, two of the three were with WPW syndrome with greatly increased voltages of the left ventricle. All the three patients had inverted T-waves, and were classified into NYHA functional class I at diagnosis, consistent with previous studies. 1, 9 Arad et al. 1 reported that five of six Danon disease patients were boys with mean age of 15 years, and five patients were with WPW syndrome and markedly increased left ventricular voltage. Maron et al. 9 reported that six of seven Danon disease patients were boys with a median age of 14 years, and six patients were with WPW syndrome and deeply inverted T-waves at diagnosis. Furthermore, all the three patients had markedly elevated serum hepatic enzymes and CK concentrations, consistent with previous studies by Yang et al., 7 Maron et al., 9 Cottinet et al., 10 Balmer et al., 11 and Morisawa et al.
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Another important finding of the present study was three novel frameshift mutations of the LAMP2 gene. They were c.808_809 insG in exon 6, c.320_321 insCATC in exon 3, and c.257_258 delCC in exon 3; all the frameshift mutations led to a premature stop codon on cDNA analysis. The cardiac phenotype of Danon disease is severe with early onset and poor prognosis. In a study of 20 male patients, the mean age at onset was 17 years (range from 10 months to 19 years), and all patients except one died before the age of 30 years. 2 Maron et al. 9 reported that each of the seven Danon disease patients experienced serious adverse clinical consequences by 14-24 years of age (mean: 21 years), four patients died of acute or progressive heart failure, and one patient underwent heart transplantation; all seven patients had received implantable cardioverter defibrillators (ICDs), which ultimately failed to terminate lethal ventricular tachyarrthymias in five. Therefore, physicians should consider early intervention with heart transplantation 2, 13 once left ventricular dysfunction occurs, despite the possibility of extracardiac organ involvement of this disease. 2, 8 To distinguish HCM from Danon disease is important, as there are some Danon disease patients with asymmetric septal hypertrophy, 9 resembling HCM. First, majority of Danon disease patients are male teenagers with a very poor prognosis. Deaths are due to heart failure or sudden cardiac death. This is in contrast to HCM, in which cardiac death is only 1-2% per year and of which only 10% develop heart failure. 14 
